Suppr超能文献

智力和发育障碍与 COVID-19 病死率趋势:TriNetX 分析。

Intellectual and developmental disability and COVID-19 case-fatality trends: TriNetX analysis.

机构信息

Department of Physical Medicine & Rehabilitation, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.

Department of Sociology and Aging Studies Institute, Maxwell School of Citizenship and Public Affairs, Syracuse University, Syracuse, NY, 13244, USA.

出版信息

Disabil Health J. 2020 Jul;13(3):100942. doi: 10.1016/j.dhjo.2020.100942. Epub 2020 May 24.

Abstract

BACKGROUND

Despite possibly higher risk of severe outcomes from COVID-19 among people with intellectual and developmental disabilities (IDD), there has been limited reporting of COVID-19 trends for this population.

OBJECTIVE

To compare COVID-19 trends among people with and without IDD, overall and stratified by age.

METHODS

Data from the TriNetX COVID-19 Research Network platform was used to identify COVID-19 patients. Analysis focused on trends in comorbidities, number of cases, number of deaths, and case-fatality rate among patients with and without IDD who had a positive diagnosis for COVID-19 through May 14, 2020.

RESULTS

People with IDD had higher prevalence of specific comorbidities associated with poorer COVID-19 outcomes. Distinct age-related differences in COVID-19 trends were present among those with IDD, with a higher concentration of COVID-19 cases at younger ages. In addition, while the overall case-fatality rate was similar for those with IDD (5.1%) and without IDD (5.4%), these rates differed by age: ages ≤17 - IDD 1.6%, without IDD <0.01%; ages 18-74 - IDD 4.5%, without IDD 2.7%; ages ≥75- IDD 21.1%, without IDD, 20.7%.

CONCLUSIONS

Though of concern for all individuals, COVID-19 appears to present a greater risk to people with IDD, especially at younger ages. Future research should seek to document COVID-19 trends among people with IDD, with particular attention to age related trends.

摘要

背景

尽管智障和发育障碍患者(IDD)感染 COVID-19 后出现严重后果的风险可能更高,但针对这一人群的 COVID-19 趋势报告有限。

目的

比较 IDD 患者和非 IDD 患者的 COVID-19 趋势,总体上和按年龄分层。

方法

使用 TriNetX COVID-19 研究网络平台的数据来识别 COVID-19 患者。分析重点是在 2020 年 5 月 14 日之前,COVID-19 诊断呈阳性的 IDD 和非 IDD 患者的合并症、病例数、死亡数和病死率趋势。

结果

ID 患者存在与 COVID-19 结局较差相关的特定合并症的患病率较高。在 IDD 患者中,COVID-19 趋势存在明显的年龄相关差异,年龄较小的患者 COVID-19 病例更为集中。此外,尽管 IDD(5.1%)和非 IDD(5.4%)患者的总体病死率相似,但这些比率因年龄而异:年龄≤17- IDD 1.6%,非 IDD <0.01%;年龄 18-74- IDD 4.5%,非 IDD 2.7%;年龄≥75- IDD 21.1%,非 IDD 20.7%。

结论

尽管 COVID-19 对所有人都构成关注,但它似乎对 IDD 患者构成更大的风险,尤其是在年龄较小的患者中。未来的研究应致力于记录 IDD 患者的 COVID-19 趋势,特别关注与年龄相关的趋势。

相似文献

1
Intellectual and developmental disability and COVID-19 case-fatality trends: TriNetX analysis.
Disabil Health J. 2020 Jul;13(3):100942. doi: 10.1016/j.dhjo.2020.100942. Epub 2020 May 24.
2
COVID-19 outcomes among people with intellectual and developmental disability living in residential group homes in New York State.
Disabil Health J. 2020 Oct;13(4):100969. doi: 10.1016/j.dhjo.2020.100969. Epub 2020 Jun 24.
3
Supporting individuals with intellectual and developmental disability during the first 100 days of the COVID-19 outbreak in the USA.
J Intellect Disabil Res. 2020 Jul;64(7):489-496. doi: 10.1111/jir.12740. Epub 2020 Jun 3.
4
COVID-19 and the Field of Intellectual and Developmental Disabilities: Where Have We Been? Where Are We? Where Do We Go?
Intellect Dev Disabil. 2020 Aug 1;58(4):257-261. doi: 10.1352/1934-9556-58.4.257.
7
COVID-19 case-fatality disparities among people with intellectual and developmental disabilities: Evidence from 12 US jurisdictions.
Disabil Health J. 2021 Oct;14(4):101116. doi: 10.1016/j.dhjo.2021.101116. Epub 2021 May 14.

引用本文的文献

1
Long term trends in NHS inpatient bed provision in England, 1960-2020.
PLoS One. 2025 Aug 29;20(8):e0330931. doi: 10.1371/journal.pone.0330931. eCollection 2025.
2
Enhancing Healthcare for People with Disabilities Through Artificial Intelligence: Evidence from Saudi Arabia.
Healthcare (Basel). 2025 Jul 6;13(13):1616. doi: 10.3390/healthcare13131616.
8
The Impact of the COVID-19 Pandemic on Individuals with Down Syndrome: A Croatian Survey.
Balkan J Med Genet. 2024 Sep 6;27(1):51-58. doi: 10.2478/bjmg-2024-0007. eCollection 2024 Jun.
9

本文引用的文献

2
Geographic Differences in COVID-19 Cases, Deaths, and Incidence - United States, February 12-April 7, 2020.
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):465-471. doi: 10.15585/mmwr.mm6915e4.
4
Covid-19: risk factors for severe disease and death.
BMJ. 2020 Mar 26;368:m1198. doi: 10.1136/bmj.m1198.
5
Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020.
MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):343-346. doi: 10.15585/mmwr.mm6912e2.
6
7
Heterogeneity in age at death for adults with developmental disability.
J Intellect Disabil Res. 2019 Dec;63(12):1482-1487. doi: 10.1111/jir.12672. Epub 2019 Jul 16.
8
Improving Public Health Requires Inclusion of Underrepresented Populations in Research.
JAMA. 2018 Jan 23;319(4):337-338. doi: 10.1001/jama.2017.19138.
9
The Intellectual Disability Mortality Disadvantage: Diminishing With Age?
Am J Intellect Dev Disabil. 2017 Mar;122(2):192-207. doi: 10.1352/1944-7558-122.2.192.
10
Persons with disabilities as an unrecognized health disparity population.
Am J Public Health. 2015 Apr;105 Suppl 2(Suppl 2):S198-206. doi: 10.2105/AJPH.2014.302182. Epub 2015 Feb 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验